BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33360835)

  • 1. Ca
    Silveirinha VC; Lin H; Tanifuji S; Mochida S; Cottrell GS; Cimarosti H; Stephens GJ
    Cell Calcium; 2021 Jan; 93():102326. PubMed ID: 33360835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
    Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
    Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
    Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
    J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIM1α SUMOylation is required for fast synaptic vesicle exocytosis.
    Girach F; Craig TJ; Rocca DL; Henley JM
    Cell Rep; 2013 Dec; 5(5):1294-301. PubMed ID: 24290762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.
    Ju W; Li Q; Wilson SM; Brittain JM; Meroueh L; Khanna R
    Channels (Austin); 2013; 7(3):153-9. PubMed ID: 23510938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Neurexins Together with α2δ-1 Auxiliary Subunits Regulate Ca
    Brockhaus J; Schreitmüller M; Repetto D; Klatt O; Reissner C; Elmslie K; Heine M; Missler M
    J Neurosci; 2018 Sep; 38(38):8277-8294. PubMed ID: 30104341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals.
    Feligioni M; Nishimune A; Henley JM
    Eur J Neurosci; 2009 Apr; 29(7):1348-56. PubMed ID: 19344328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pellino-1, an adaptor protein of interleukin-1 receptor/toll-like receptor signaling, is sumoylated by Ubc9.
    Kim JH; Sung KS; Jung SM; Lee YS; Kwon JY; Choi CY; Park SH
    Mol Cells; 2011 Jan; 31(1):85-9. PubMed ID: 21120624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
    J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
    J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E; Schröder-Kress N; Sticht H; Enz R
    Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
    Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
    EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K; Lee TD; Chen Y
    J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Parkin in the ubiquitin proteasome system-mediated degradation of N-type voltage-gated Ca2+ channels.
    Grimaldo L; Sandoval A; Garza-López E; Felix R
    PLoS One; 2017; 12(9):e0185289. PubMed ID: 28957379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5.
    Benson MD; Li QJ; Kieckhafer K; Dudek D; Whorton MR; Sunahara RK; Iñiguez-Lluhí JA; Martens JR
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1805-10. PubMed ID: 17261810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Transthyretin a Regulator of Ubc9 SUMOylation?
    Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
    PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.